| 1. |
- Claesson, Åsa, et al.
(författare)
-
Novel Er:Yb phosphate glass fiber laser pumped by a 946 nm Nd:YAG laser
- 2001
-
Ingår i: Technical Digest. Summaries of papers presented at the Conference on Lasers and Electro-Optics. Postconference Technical Digest (IEEE Cat. No.01CH37170).
-
Konferensbidrag (refereegranskat)abstract
- Summary form only given. Recently, Kigre introduced a new family of rare-earth doped fibers (Wu et al, 2000), based on phosphate laser glass. Due to their phonon energy, erbium-doped phosphate glasses exhibit lower up-conversion losses than silica glass. This, and the high solubility for rare-earth ions, makes phosphate glasses promising candidates for high-gain erbium devices. High doping concentrations enable short devices, and fiber lasers or amplifiers with only a few centimeters of active fiber can be realized. This is to be compared to standard EDFAs that normally contain tens of meters of erbium-doped silica fibers. We have demonstrated a short fiber-laser based on a single-mode Er:Yb codoped phosphate fiber, pumped by a 946 nm Nd:YAG laser.
|
|
| 2. |
|
|
| 3. |
- Morris, Simon, et al.
(författare)
-
The ELT-MOS (MOSAIC) : towards the construction phase
- 2018
-
Ingår i: GROUND-BASED AND AIRBORNE INSTRUMENTATION FOR ASTRONOMY VII. - : SPIE-INT SOC OPTICAL ENGINEERING. - 9781510619586 ; 10702
-
Konferensbidrag (refereegranskat)abstract
- When combined with the huge collecting area of the ELT, MOSAIC will be the most effective and flexible Multi-Object Spectrograph (MOS) facility in the world, having both a high multiplex and a multi-Integral Field Unit (Multi-IFU) capability. It will be the fastest way to spectroscopically follow-up the faintest sources, probing the reionisation epoch, as well as evaluating the evolution of the dwarf mass function over most of the age of the Universe. MOSAIC will be world-leading in generating an inventory of both the dark matter (from realistic rotation curves with MOAO fed NIR IFUs) and the cool to warm-hot gas phases in z=3.5 galactic haloes (with visible wavelenth IFUs). Galactic archaeology and the first massive black holes are additional targets for which MOSAIC will also be revolutionary. MOAO and accurate sky subtraction with fibres have now been demonstrated on sky, removing all low Technical Readiness Level (TRL) items from the instrument. A prompt implementation of MOSAIC is feasible, and indeed could increase the robustness and reduce risk on the ELT, since it does not require diffraction limited adaptive optics performance. Science programmes and survey strategies are currently being investigated by the Consortium, which is also hoping to welcome a few new partners in the next two years.
|
|
| 4. |
- Brown, Darron R., et al.
(författare)
-
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
- 2009
-
Ingår i: Journal Of Infectious Diseases. - : Oxford University Press (OUP). - 0022-1899 .- 1537-6613. ; 199:7, s. 926-935
-
Konferensbidrag (refereegranskat)abstract
- Background. Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18-related cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1-3/AIS associated with nonvaccine oncogenic HPV types was evaluated. Methods. We enrolled 17,622 women aged 16-26 years. All underwent cervicovaginal sampling and Pap testing at regular intervals for up to 4 years. HPV genotying was performed for biopsy samples, and histological diagnoses were determined by a pathology panel. Analyses were conducted among subjects who were negative for 14 HPV types on day 1. Prespecified analyses included infection of >= 6 months' duration and CIN1-3/AIS due to the 2 and 5 most common HPV types in cervical cancer after HPV types 16 and 18, as well as all tested nonvaccine types. Results. Vaccination reduced the incidence of HPV-31/45 infection by 40.3% (95% confidence interval [CI], 13.9% to 59.0%) and of CIN1-3/AIS by 43.6% (95% CI, 12.9% to 64.1%), respectively. The reduction in HPV-31/33/45/52/58 infection and CIN1-3/AIS was 25.0% (95% CI, 5.0% to 40.9%) and 29.2% (95% CI, 8.3% to 45.5%), respectively. Efficacy for CIN2-3/AIS associated with the 10 nonvaccine HPV types was 32.5% (95% CI, 6.0% to 51.9%). Reductions were most notable for HPV-31. Conclusions. HPV-6/11/16/18 vaccine reduced the risk of CIN2-3/AIS associated with nonvaccine types responsible for similar to 20% of cervical cancers. The clinical benefit of cross-protection is not expected to be fully additive to the efficacy already observed against HPV-6/11/16/18-related disease, because women may have >1 CIN lesion, each associated with a different HPV type.
|
|
| 5. |
- Wheeler, Cosette M., et al.
(författare)
-
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years
- 2009
-
Ingår i: Journal Of Infectious Diseases. - : Oxford University Press (OUP). - 0022-1899 .- 1537-6613. ; 199:7, s. 936-944
-
Konferensbidrag (refereegranskat)abstract
- Background. We evaluated the impact of a quadrivalent human papillomavirus (HPV) vaccine on infection and cervical disease related to 10 nonvaccine HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, and 59) associated with >20% of cervical cancers. The population evaluated included HPV-naive women and women with preexisting HPV infection and/or HPV-related disease at enrollment. Methods. Phase 3 efficacy studies enrolled 17,622 women aged 16-26 years. Subjects underwent cervicovaginal sampling and Pap testing on day 1 and then at 6-12-month intervals for up to 4 years. HPV typing was performed on samples from enrollment and follow-up visits, including samples obtained for diagnosis or treatment of HPV-related disease. All subjects who received >= 1 dose and returned for follow-up were included. Results. Vaccination reduced the rate of HPV-31/33/45/52/58 infection by 17.7% (95% confidence interval [CI], 5.1% to 28.7%) and of cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS) by 18.8% (95% CI, 7.4% to 28.9%). Vaccination also reduced the rate of HPV-31/58/59-related CIN1-3/AIS by 26.0% (95% CI, 6.7% to 41.4%), 28.1% (95% CI, 5.3% to 45.6%), and 37.6% (95% CI, 6.0% to 59.1%), respectively. Although a modest reduction in HPV-31/33/45/52/58-related CIN2 or worse was observed, the estimated reduction was not statistically significant. Conclusions. These cross-protection results complement the vaccine's prophylactic efficacy against disease associated with HPV-6, -11, -16, and - 18. Long-term monitoring of vaccinated populations are needed to fully ascertain the population-based impact and public health significance of these findings.
|
|
| 6. |
|
|
| 7. |
- Burvall, Anna, 1976-, et al.
(författare)
-
Singular-value decomposition of axial systems
- 2006
-
Ingår i: ICO Topical meeting on optoinformation/Information Photonics 2006.
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- A method for reconstruction of 3D objects from 2D images, used e.g. in fluorescence microscopy, is takingseveral images along the axial direction. Singular-value decomposition is used to perform the reconstructionand determine its limits.
|
|
| 8. |
- Feldman, G., et al.
(författare)
-
Compton scattering from deuterium and the polarizabilities of the neutron
- 2008
-
Ingår i: Few-Body Systems. - : Springer Science and Business Media LLC. - 0177-7963 .- 1432-5411. ; 44:1-4, s. 325-328
-
Konferensbidrag (refereegranskat)abstract
- A new program of Compton scattering on deuterium is under way at the tagged-photon facility at MAX-Lab in Lund, Sweden. We will measure differential cross sections between 60A degrees and 150A degrees over the photon energy range 60-115 MeV in 5 MeV steps, with the ultimate goal of obtaining new precision information on the electric and magnetic polarizabilities of the neutron.
|
|
| 9. |
|
|
| 10. |
- Johnstone, C. M., et al.
(författare)
-
EquiMar: development of best practices for the engineering performance appraisal of wave and tidal energy convertors
- 2011
-
Konferensbidrag (refereegranskat)abstract
- At the present time there are no approved standards or recognised best practices being implemented for the performance appraisal and benchmarking of wave and tidal energy converters. As such, this develops considerable misunderstanding between device developers, testing centres, investors/ financiers etc when attempting to quantify the performance of a device since it makes it very difficult to reference and benchmark the performance of a marine energy converter. The EC Framework Programme VII EquiMar project has set out to develop a suite of Best Practices to be adopted when undertaking the performance evaluation of such systems in order to address this deficiency. This paper reports the development of a set of ‘Best Practices’ within the ECFPVII EquiMar project to be adopted for the performance quantification of wave and tidal energy converters as they evolve from an engineering concept to commercial scale deployment
|
|
